These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 34849272)
41. Identification of a novel TSC1 gene variant in a patient with atypical vitiligo-like skin lesions: Unveiling the hidden tuberous sclerosis complex. Liu L; Wang Y; Zhang Z; Yu C; Chen J Mol Genet Genomic Med; 2024 Mar; 12(3):e2403. PubMed ID: 38439608 [TBL] [Abstract][Full Text] [Related]
42. Tuberous sclerosis: diagnosis and prenatal diagnosis by MLPA. Padma Priya T; Dalal AB Indian J Pediatr; 2012 Oct; 79(10):1366-9. PubMed ID: 21541650 [TBL] [Abstract][Full Text] [Related]
43. Diagnosis and genotype-phenotype correlation in patients with PKD1/TSC2 contiguous gene deletion syndrome. Shang S; Mei Y; Wang T; Zheng X; Chen K; Xiong S; Dong Y; Chang Y; Wu X; Kong X; Tan M; Wu L; Zhang Y; Xiao Y; Xie Y; Cai G; Chen X; Li Q Clin Nephrol; 2022 Jun; 97(6):328-338. PubMed ID: 35142283 [TBL] [Abstract][Full Text] [Related]
44. Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome. Back SJ; Andronikou S; Kilborn T; Kaplan BS; Darge K Pediatr Radiol; 2015 Mar; 45(3):386-95. PubMed ID: 25355409 [TBL] [Abstract][Full Text] [Related]
45. Molecular and clinical analyses of 84 patients with tuberous sclerosis complex. Hung CC; Su YN; Chien SC; Liou HH; Chen CC; Chen PC; Hsieh CJ; Chen CP; Lee WT; Lin WL; Lee CN BMC Med Genet; 2006 Sep; 7():72. PubMed ID: 16981987 [TBL] [Abstract][Full Text] [Related]
46. Stochastic model of Tsc1 lesions in mouse brain. Prabhakar S; Goto J; Zhang X; Sena-Esteves M; Bronson R; Brockmann J; Gianni D; Wojtkiewicz GR; Chen JW; Stemmer-Rachamimov A; Kwiatkowski DJ; Breakefield XO PLoS One; 2013; 8(5):e64224. PubMed ID: 23696872 [TBL] [Abstract][Full Text] [Related]
47. Atypical noncontiguous TSC2/PKD1 gene deletions presenting as tuberous sclerosis/polycystic kidney disease contiguous gene syndrome. Ventayol-Guirado M; Torres L; Asensio-Landa V; Pérez-Granero Á; Madrid MI; Hernandez-Rodriguez J; Llull-Alberti MV; Lumbreras J; Escribà S; Pons M; Roldan J; Martínez-López I; Heine-Suñer D; Santos-Simarro F Am J Med Genet A; 2024 Dec; 194(12):e63830. PubMed ID: 39095963 [TBL] [Abstract][Full Text] [Related]
48. Tuberous Sclerosis Complex: Clinical Spectrum and Epilepsy: A Retrospective Chart Review Study. Almobarak S; Almuhaizea M; Abukhaled M; Alyamani S; Dabbagh O; Chedrawi A; Khan S; Aldhalaan H Transl Neurosci; 2018; 9():154-160. PubMed ID: 30479846 [TBL] [Abstract][Full Text] [Related]
49. Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions. Niida Y; Stemmer-Rachamimov AO; Logrip M; Tapon D; Perez R; Kwiatkowski DJ; Sims K; MacCollin M; Louis DN; Ramesh V Am J Hum Genet; 2001 Sep; 69(3):493-503. PubMed ID: 11468687 [TBL] [Abstract][Full Text] [Related]
50. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex. Zeng LH; Rensing NR; Zhang B; Gutmann DH; Gambello MJ; Wong M Hum Mol Genet; 2011 Feb; 20(3):445-54. PubMed ID: 21062901 [TBL] [Abstract][Full Text] [Related]
51. Tuberous sclerosis complex and DNA repair. Habib SL Adv Exp Med Biol; 2010; 685():84-94. PubMed ID: 20687497 [TBL] [Abstract][Full Text] [Related]
52. The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas. Plank TL; Logginidou H; Klein-Szanto A; Henske EP Mod Pathol; 1999 May; 12(5):539-45. PubMed ID: 10349994 [TBL] [Abstract][Full Text] [Related]
53. Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/- cells. Uhlmann EJ; Apicelli AJ; Baldwin RL; Burke SP; Bajenaru ML; Onda H; Kwiatkowski D; Gutmann DH Oncogene; 2002 Jun; 21(25):4050-9. PubMed ID: 12037687 [TBL] [Abstract][Full Text] [Related]
54. Electro-clinical and neurodevelopmental outcome in six children with early diagnosis of tuberous sclerosis complex and role of the genetic background. Savini MN; Mingarelli A; Peron A; La Briola F; Cervi F; Alfano RM; Canevini MP; Vignoli A Ital J Pediatr; 2020 Mar; 46(1):36. PubMed ID: 32216820 [TBL] [Abstract][Full Text] [Related]
55. [Tuberous sclerosis complex: A review]. Pfirmann P; Combe C; Rigothier C Rev Med Interne; 2021 Oct; 42(10):714-721. PubMed ID: 33836894 [TBL] [Abstract][Full Text] [Related]
56. Genotypic and phenotypic analysis of Korean patients with tuberous sclerosis complex. Shin HJ; Lee S; Kim SH; Lee JS; Oh JY; Ko A; Kang HC Neurogenetics; 2024 Oct; 25(4):471-479. PubMed ID: 39110368 [TBL] [Abstract][Full Text] [Related]
57. Molecular analysis of TSC2/PKD1 contiguous gene deletion syndrome. Oyazato Y; Iijima K; Emi M; Sekine T; Kamei K; Takanashi J; Nakao H; Namai Y; Nozu K; Matsuo M Kobe J Med Sci; 2011 Jun; 57(1):E1-10. PubMed ID: 22169896 [TBL] [Abstract][Full Text] [Related]
58. Genotype and brain pathology phenotype in children with tuberous sclerosis complex. Overwater IE; Swenker R; van der Ende EL; Hanemaayer KB; Hoogeveen-Westerveld M; van Eeghen AM; Lequin MH; van den Ouweland AM; Moll HA; Nellist M; de Wit MY Eur J Hum Genet; 2016 Dec; 24(12):1688-1695. PubMed ID: 27406250 [TBL] [Abstract][Full Text] [Related]
59. Risk factors for the development of autism spectrum disorder in children with tuberous sclerosis complex: protocol for a systematic review. Mitchell R; Barton S; Harvey AS; Williams K Syst Rev; 2017 Mar; 6(1):49. PubMed ID: 28270230 [TBL] [Abstract][Full Text] [Related]
60. TSC1 and TSC2 gene mutations and their implications for treatment in Tuberous Sclerosis Complex: a review. Rosset C; Netto CBO; Ashton-Prolla P Genet Mol Biol; 2017; 40(1):69-79. PubMed ID: 28222202 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]